Artelo Biosciences【ARTL】銘柄情報

Artelo Biosciences Inc (ARTL) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

1.08

( -1.82% )

買値

1.08

売値

1.09

出来高

135,698

1.06 日の範囲 1.11

1.03 52 週間の範囲 28.60

時価総額

3.764M

前日終値

1.10

始値

1.11

時刻

1.09

最終取引時間

財務取引量

US$ 147,228

VWAP

1.085

平均取引量 (3 か月)

US$ 1,849,141

発行済株式数

3,485,540

配当利回り

PER

-0.04

1 株当たり利益 (EPS)

-28.02

歳入

純利益

-13.47M

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company’s product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which... Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company’s product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, and other potential indications. It also offers ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

artelobio.com

本社

Solana Beach, United States

設立

2026

Artelo Biosciences Inc is listed in the Healthcare sector of the ナスダック市場 with ticker ARTL. The last closing price for Artelo Biosciences was US$1.10. Over the last year, Artelo Biosciences shares have traded in a share price range of US$ 1.03 to US$ 28.60.

Artelo Biosciences currently has 3,485,540 shares in issue. The market capitalisation of Artelo Biosciences is US$3.76 million. Artelo Biosciences has a price to earnings ratio (PE ratio) of -0.04.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Artelo Biosciences Announces New Data Supporting ART26.12 as a Potential First-in-Class Therapy for Chronic Pain associated with Spinal Cord Injury

SOLANA BEACH, Calif., July 01, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or...

Artelo Biosciences Presents Evidence for a Common Lipid-Signaling Link Across Multiple Potential Indications for Its FABP5 Inhibitor Platform at ICRS 2026

SOLANA BEACH, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a...

Artelo Biosciences Presents Clinical and Biomarker Data Supportive of the Development of ART26.12 and Follow-On FABP5 Inhibitors at ICRS 2026

First-in-Human Results Demonstrate Favorable Safety and Pharmacokinetics Profile AI Aided Target Engagement...

Form PRER14A - Preliminary Proxy Soliciting materials

Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success

SOLANA BEACH, Calif., June 10, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.08	-6.89655172414	1.16	1.19	1.03	398121	1.10667711	CS
4	-0.33	-23.4042553191	1.41	1.5396	1.03	297659	1.24100948	CS
12	-5.39	-83.3075734158	6.47	6.91	1.03	1761991	2.6130921	CS
26	-0.25	-18.7969924812	1.33	19.9099	1.03	2244243	6.45641694	CS
52	-8.73	-88.9908256881	9.81	28.6	1.03	1322065	6.29564565	CS
156	-0.87	-44.6153846154	1.95	28.6	0.8196	551447	6.1046779	CS
260	-0.08	-6.89655172414	1.16	28.6	0.2599	877313	2.92464337	CS